Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PVX 7

Next Previous
Drug Profile

PVX 7

Alternative Names: HPV16/18; pBI-11; pBI-11 plasmid DNA; pBI-11/TA-HPV; PVX-7

Latest Information Update: 16 Jul 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PAPIVAX
  • Developer John Hopkins University; PAPIVAX
  • Class Antineoplastics; Cancer vaccines; DNA vaccines; Immunotherapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Human papillomavirus infections

Most Recent Events

  • 25 Jun 2026 Phase-II clinical trials in Human papillomavirus infections in USA (IM) (NCT06210854)
  • 18 Jan 2024 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins plans a phase II trial in Human papillomavirus infections (Intradermal, IM) in January 2024 (NCT06210854)
  • 16 May 2023 Phase-II clinical trials in Human papillomavirus infections (Metastatic disease, Combination therapy, Recurrent, Late-stage disease, First-line therapy) in USA (IM) (NCT05799144)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top